Gregg Anthony Lapointe founded Cerium Pharmaceuticals, Inc.
He is Chairman at Horizon Pharmaceutical LLC.
He is also on the board of Soligenix, Inc., Rigel Pharmaceuticals, Inc., Catabasis Pharmaceuticals, Inc. and S1 BioPharma, Inc. and Member-Corporate Council at Child Neurology Foundation and Member-Corporate Council at Kidney Care Partners.
He previously occupied the position of Chief Executive Officer for Cerium Pharmaceuticals, Inc., Chief Executive Officer for Essetifin SpA, Chief Executive Officer of Leadiant Biosciences, Inc., Vice President-Operations & Controller at AstenJohnson, Inc. and Member-Corporate Council at The National Organization for Rare Disorders, Inc.
Mr. Lapointe received an undergraduate degree from Concordia University, an MBA from Duke University and an undergraduate degree from McGill University.